Canned Oxygen, Ice Tubs and a Billion-Dollar Supplement Trade: The Evidence Gap Inside Football's Recovery Industry

The question arrived in a tin can. Someone at the training ground handed it over and said recovery would speed up. Claire-Marie Roberts asked a simple question back: on what evidence? No clear answer came. Nine seasons in the Premier League, a promotion success at Coventry City, and now Director of Human Performance at McLaren in Formula 1 — across that road she learned that football receives more than fifty pitches a week for miraculous fixes. They do not arrive as research papers. They arrive in LinkedIn messages, in vendor emails, in the annexes of sponsorship deals.

The charge Roberts makes is structural. In an interview published by The Guardian and republished by VnExpress in 2026, she argued that professional football's recovery and preparation culture runs largely on imitation, marketing and belief rather than evidence. Born in 2026, she was a swimmer whose path to the 2026 Olympics was cut short by injury, and that experience later became the foundation of her professional authority. Inside football's performance departments she found coaches and fitness specialists who are sincerely deceived. Nobody has to be a fraud for the system to be fraudulent.

The issue sharpens during a tournament cycle. In a live competition, recovery pressure rises across every squad, supplement use rises with it, and the time available to verify evidence falls. The market carrying all this is not small. Supplements are now a billion-dollar industry, and it has not entered football with a soft hand — it has entered carrying direct sales pressure.

Cryotherapy is where the problem is easiest to see. Almost every expensive training centre now has a cryotherapy chamber installed; ice baths, once the backup, now sit beside it. A single Director of Performance receives more than fifty inbound pitches each week. That is not networking. That is pressure. Roberts' observation is that there is no clear scientific evidence for cold therapy, only a small handful of narrow studies, and some recent work pointing the other way: excessive cold may blunt muscle adaptability. The device installed to accelerate recovery may be obstructing it.

The most expensive training centres in football carry that risk while the evidentiary gap goes unacknowledged in public. Her counter-model is irritably simple. Sleep and nutrition are the foundation; everything else is frontier work. Supplements should be used only when a deficiency has been demonstrated. Mix the three tiers — foundation, supplement, experimental — and the budget flows toward the chamber while accountability flows somewhere else entirely.

Kinesiology tape carries a different problem: the image is beautiful. Cristiano Ronaldo, Gareth Bale, David Beckham — years of elite football have burned the taped leg into our visual memory. There is no evidence that tape prevents injury, yet the tape market grows, because visibility has a price. We default to treating what the camera shows as what is true. I recognise that habit from my own trade. In VAR, a camera angle shapes the decision, and evidence and belief do not become the same thing — except in the viewer's eye, where they do. While reviewing 172 incidents at Qatar 2026 and flagging nine clear errors, that was exactly the trap I logged first.

The supplement question is the heaviest, because the risk is not only to performance but to careers. Anti-doping operates on strict liability: if a prohibited substance is in the body, the athlete carries the sanction regardless of intent. A contaminated supplement is therefore the shortest route to the end of a career. Roberts compares the vendors to illegal profiteering. The comparison is harsh and not unreasonable, because the buyer is information-poor and that weakness is monetised through packaging, promises and imagery.

The problem transmits through a chain of imitation. Manchester City, Chelsea and the England national team set the trend; the copying queue forms behind them. What a resource-rich club holds, a lower-resource club does not, yet the fidelity of the copying is higher lower down. A club without its own science department reproduces most faithfully the practices with the weakest evidence. Roberts' assessment is that the situation is getting worse than before. To a referee's eye this is a familiar design: the reference anchor decides what looks correct, and everyone shifts toward it, whatever the evidence says.

There is a hidden conflict of interest here too. Cryotherapy suppliers, supplement brands and tape manufacturers frequently hold club sponsorship and partnership deals. A product with space on the club's billboard needs less of a push to get through the door of the club's protocol.

I learned the offside line from a campus blog long before I ever saw a live feed. In 2026 in Mymensingh I manually coded 34 Bangladesh Premier League matches and 12 controversial calls, testing whether camera position predicted referee accuracy. Calibrating offside lines across 18 matches of the 2026 behind-closed-doors BPL season, I found that in an empty stadium, with the crowd gone, the decision tree becomes louder than the crowd.

One conclusion held: football's evidence gap in performance science does not stay inside the physio room. The accuracy of the referee sprinting the line in the 88th minute depends on sleep, hydration and the fatigue accumulated in a third match of a tournament. Yet in Bangladesh's domestic football, referee recovery protocols are close to non-existent — few physios, no data, and limited habit of tracking the salt lost in sweat through a humid season.

Our market holds a layer that European debate rarely touches. From Dhaka pharmacies to online pages, imported supplements crowd the shelf; young players buy them because seniors use them, not because test reports support them. Where a club has few medical staff, the decision migrates to the player, and a decision in the player's hands is a decision in the market's hands. This is not a direct translation of the British story. Here the filter deficit is steeper, because nobody has yet settled who pays to build the filter. I will not recommend importing a British model. The work has to start from the data we already hold.

A counter-question is owed here, because absence of evidence is not the same as absence of effect. Ice tubs, tape and routine are ritual to a player, and ritual builds confidence. Placebo can improve performance; that is not bad science, it is a different phenomenon. The trouble begins when ritual is sold as method and club budgets are allocated in that name.

The second uncomfortable truth is that copying is not irrational. In an information-poor environment, imitating Manchester City is a reasonable strategy — without your own laboratory, following a proven winner is the safe side. The bill lands on the club that has no filter. And the thing least visible to us as viewers is neither the ice tub nor the tape. It is controlled supplement dosing. It does not photograph well and it does not go viral, yet under strict liability a single contaminated capsule can erase a career.

In tournament fever we love the accounting of who bought what at what price. We keep no ledger of who recovers by the rules. I log the error first, then write the story around it. Performance departments need the same process: which method, at which tier, on what source. If Bangladesh begins that today, a cheap decision habit forms before the expensive chamber is ordered — and it will not have to be dismantled later.